openPR Logo
Press release

Tumor Ablation Market Size, Share, Trends, Demand, Growth, Regional Analysis And Industry Forecast 2027

01-28-2022 10:55 AM CET | Health & Medicine

Press release from: Market Research Future (MRFR)

Tumor Ablation Market

Tumor Ablation Market

Market Highlights:
Tumor ablation is a technique of removal of cancer tissue or cells of kidney, liver, bone, and soft tissue with invasive procedure. It is considered as excellent and convenient treatment option over other conventional surgical techniques. Factors that are propelling the growth of the tumor ablation market are surge in geriatric population, increase in prevalence of different types of cancer, rise in adoption of minimally invasive surgical procedures, increasing research and development in healthcare and advancement in technologies.

Get Sample Report @

The preference for minimally invasive image-guided techniques is motivating the demand for tumor ablation devices considerably. Reports that review the medical device industry have been offered by Market Research Future, which generates reports on industry verticals that evaluate the market development and opportunities. The market is on track to achieve a CAGR of 12.8 % approximately in the forecast period.

The surge in the detection of cancerous tissues in kidney, liver, soft tissue, and bone is motivating the need for tumor ablation greatly. The success rates of tumor ablation devices are also significantly encouraging the growth of the market globally. Also, the improvement in manufacturing of tumor ablation devices is anticipated to prompt favorable growth in the market.

Segmental Analysis
The segmental study of the tumor ablation market has been segmented on the basis of treatment, application, technology, region, and end-user. Based on the technology, the tumor ablation market has been segmented into microwave, irreversible electroporation, radiofrequency, cryoablation, and others. On the basis of treatment, the market for tumor ablation has been segmented into percutaneous, surgical, and laparoscopic. Application-based segmentation of the tumor ablation market comprises of bone cancer, lung cancer, liver cancer, breast cancer, prostate cancer, and others. Based on the end-user, the tumor ablation market has been segmented into surgical and ablation centers, hospitals, and research institute. Based on the regions, the tumor ablation market comprises of Europe, Asia Pacific, the Americas, and the Middle East & Africa.

Key Players:
Some of the key players in the global tumor ablation market are SonaCare Medical, Medtronic Plc., EDAP TMS, AngioDynamics Inc., Healthtronics Inc., Neuwave Medical, Inc., Boston Scientific Corporation, Galil Medical, Inc, Misonix Inc., and Covidien PL

Detailed Regional Analysis
The regional assessment of the tumor ablation market comprises of regions such as Europe, Asia Pacific, the Americas, and the Middle East & Africa. The Americas regions are anticipated to govern the tumor ablation market due to the growing pool of cancer patients related with increasing elderly population, promising reimbursement policies, and acceptance of progressive healthcare facilities together with augmented awareness about cancer detection and treatment in general population. The European region market is projected to be the second principal tumor ablation market. The market progress in this region can be credited to the growing occurrence of cancer along with expanding healthcare spending, which is expected to motivate the growth of the market. The APAC region is anticipated to be the fastest mounting tumor ablation market throughout the forecast period due to the mounting elderly population in the region, constantly growing investment in healthcare and elevated demand for advanced technologies in healthcare. The market in the Middle East & Africa region is anticipated to be responsible for the minimum portion of the tumor ablation market owing to an underdeveloped healthcare sector, absence of technical knowledge, and deprived medical facilities.

Competitive Analysis
The presence of successful products and brands is shaping the development of the market to a great extent. The key success factors are also favorably contributing to the growth of the market. The fortification of the distribution channels in the market is expected to increase the penetration of the products. In the coming years, market profitability will progressively improve as innovation and product developments induce positive developments. The industry cost structure is also expected to alter progressively in the coming future. The market scenario is highly dependent on the factors that are shaping the opportunities and the challenges that are existing in the market. The competitors in the market are ensuring that the product and services being offered in the market are aligning with the preferences of their user base favorably. The innovative trends emerging in the market are expected to set grounds for robust development in the approaching period. The market size is also expected to grow significantly in the coming years. Also, the progress of technology has gained momentum leading to enhanced market growth.

Access full report @

Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tumor Ablation Market Size, Share, Trends, Demand, Growth, Regional Analysis And Industry Forecast 2027 here

News-ID: 2539923 • Views: 218

More Releases from Market Research Future (MRFR)

Sports Medicine Market expected to reach US$9,655.6 million By 2023 at CAGR of 8 …
The global sports medicine market will grow at a CAGR of 8.9% during the forecast period 2017 to 2023. The market for sports medicine is set to reach US$9,655.6 million by 2023. As per sports medicine analysts, the global market is anticipated to witness growth owing to the factors such as on-going technological development as well as the expansion of medical associations. However, sports medicine will face challenges and restraints
Intravenous Immunoglobulin Market at a CAGR of 6.30 % to hit USD 10,485.86 Milli …
The global intravenous immunoglobulin market size is expected to grow by 6.30 % and is expected to reach USD 10,485.86 Million by 2023.Immunoglobins are antibodies which are produced naturally by the immune system, that helps in fighting disease and infection. IVIg or intravenous immunoglobulin is a treatment which combines immunoglobins that different people donate and is provided through a drip for treating various conditions including inflammatory conditions and immune deficiency
Compound Feed Market, Key Players Analysis, Business Growth, Regional Trends, De …
Market Overview Market Research Future (MRFR) assessed the global compound feed market 2020 for the assessment period till 2023. The global compound feed market value can expand at 4.02% CAGR through the review period. By 2023, the compound feed market can value at USD 539.99 Bn, asserts MRFR findings. Covid-19 analysis on compound feed market is released with the report. Information offered under Covid-19 compound feed market analysis by proficient researchers
Biological Seed Treatment Market, Industry Size, Share Leaders, Current Status b …
Market Highlights Demand for biologically treated seeds is fuelled by growing understanding of seed care, environmental issues and increasing demand for organic food production, and an overall emphasis on increasing the quality of agricultural produce. The industry is impacted by the introduction of sustainable farming practises, along with major market players making heavy investments in the research and production of these goods. Over the projected era, rising demand for chemical-free crops

All 5 Releases

More Releases for Tumor

Global Tumor Ablation Market Outlook To 2026
Global Tumor Ablation Market Outlook To 2026: In-Depth Market Overview, Key Treatment Type (Surgical, Percutaneous), Technology (Cryoablation, IRE, MWA, RFA), Application Categories (Liver, Lung, Breast, Prostate), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast And Conclusion The Tumor Ablation Market was valued at $1.08Billion in 2018 and is forecast to grow at a modest12.2% CAGR between2018 and 2025, culminating in 2026 global sales of $4.2Billion. Tumor Ablation
Global Tumor Ablation Devices Market - Insights
Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012. Click To Continue Reading: Tumor Ablation devices market
Global Tumor Ablation Devices Market - Insights
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators,
Tumor Ablation Market: Industry Evolution/Development
A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market
Tumor Necrosis Factor Receptor with their unique quality of simplifying the market research study, presents a deep diving study report “Tumor Necrosis Factor - Pipeline Review, H2 2017” Tumor Necrosis Factor Overview Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed
Personalised tumor vaccines keep cancer in check
Throughout the last decade, novel cancer therapeutics has seen tremendous developments, through targeting tumor cell-intrinsic pathways, as well as targeting tumor cell-extrinsic factors such as growth factors. Notable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T-cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies. This creates the need for